(5-fluoro-2,4-dioxopyrimidin-1-yl)methyl 4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate
C16H24FN3O6 — CID 123823257
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5-fluoro-2,4-dioxopyrimidin-1-yl)methyl 4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate
(5-fluoro-2,4-dioxopyrimidin-1-yl)methyl 4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate (PubChem CID 123823257) has the molecular formula C16H24FN3O6 and a molecular weight of 373.38 g/mol. Its IUPAC name is (5-fluoro-2,4-dioxopyrimidin-1-yl)methyl 4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate.
Molecular Properties
| Compound Name | (5-fluoro-2,4-dioxopyrimidin-1-yl)methyl 4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate |
|---|---|
| PubChem CID | 123823257 |
| Molecular Formula | C16H24FN3O6 |
| Molecular Weight | 373.38 g/mol |
| Exact Mass | 373.16 |
| IUPAC Name | (5-fluoro-2,4-dioxopyrimidin-1-yl)methyl 4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate |
| SMILES | CC(C)CC(NC(=O)OC(C)(C)C)C(=O)OCn1cc(F)c(=O)[nH]c1=O |
| InChI | InChI=1S/C16H24FN3O6/c1-9(2)6-11(18-15(24)26-16(3,4)5)13(22)25-8-20-7-10(17)12(21)19-14(20)23/h7,9,11H,6,8H2,1-5H3,(H,18,24)(H,19,21,23) |
| InChIKey | BHQGTCUDFRZLET-UHFFFAOYSA-N |
| XLogP | 1.12 |
| TPSA | 119.49 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.38 |
| LogP ≤ 5 | 1.12 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123823257 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.